5 Results
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-34
ID: GL-C50-34
Aug 2017
Drug
Other Name(s): Onivyde® (Baxalta Canada)
Sep 2017
Regimen
Cancer facts